Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Behavioral changes associated with GLP-1 treatment may potentially influence gastric capacity over time
Compared to those using the weight loss drugs bupropion-naltrexone, those taking GLP-1 agonists like Ozempic had a: 9.09 times higher risk of pancreatitis 4.22 times higher risk of bowel obstruction 3.67 times higher risk of gastroparesis "These drugs are becoming increasingly accessible, and it is concerning that, in some cases, people can simply go online and order these kinds of medications when they may not have a full understanding of what could potentially happen
Eine weitergehende Nutzung personenbezogener Daten oder eine Weitergabe an Dritte erfolgt ohne Ihre ausdrckliche Einwilligung nicht
2025;17(8):e90021
US$ 27.27
US$ 20.70
US$ 21.51
US$ 20.71
US$ 25.84
